Anavex Life Sciences Corp (AVXL)

[Pineapple1]

Anavex Blockchain AI lifesciences (short term name change:)

Former Chief Executive Officer of Anavex (AVXL), Dr George Tidmarsh, current CEO of La Jolla Pharma (LJPC) discussed approval of Giapreza for dispersed shock. On the conference call Dr Tidmarsh thanked the FDA and noted that they had approved the NDA two months ahead of schedule. Also in working with FDA closely the FDA took a phone call on Thanksgiving day and allowed a patient to receive "use" of the drug Giapreza prior to approval.

There seems to be a new focus in relation to the FDA and the approval process. Does this help us?